key: cord-0785315-pph9k50n
authors: Sarkar, Rakesh; Mitra, Suvrotoa; Chandra, Pritam; Saha, Priyanka; Banerjee, Anindita; Dutta, Shanta; Chawla-Sarkar, Mamta
title: Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: An endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations
date: 2020-07-15
journal: bioRxiv
DOI: 10.1101/2020.07.14.203463
sha: 8ba25a7c4dfced5f3548a5a19b8dffd749a8cf00
doc_id: 785315
cord_uid: pph9k50n

Accumulation of mutations within the genome is the primary driving force for viral evolution within an endemic setting. This inherent feature often leads to altered virulence, infectivity and transmissibility as well as antigenic shift to escape host immunity, which might compromise the efficacy of vaccines and antiviral drugs. Therefore, we aimed at genome-wide analyses of circulating SARS-CoV-2 viruses for the emergence of novel co-existing mutations and trace their spatial distribution within India. Comprehensive analysis of whole genome sequences of 441 Indian SARS-CoV-2 strains revealed the occurrence of 33 different mutations, 21 being distinctive to India. Emergence of novel mutations were observed in S glycoprotein (7/33), NSP3 (6/33), RdRp/NSP12 (4/33), NSP2 (2/33) and N (2/33). Non-synonymous mutations were found to be 3.4 times more prevalent than synonymous mutations. We classified the Indian isolates into 22 groups based on the co-existing mutations. Phylogenetic analyses revealed that representative strain of each group divided themselves into various sub-clades within their respective clades, based on the presence of unique co-existing mutations. India was dominated by A2a clade (55.60%) followed by A3 (37.38%) and B (7%), but exhibited heterogeneous distribution among various geographical regions. The A2a clade mostly predominated in East India, Western India and Central India, whereas A3 clade prevailed in South and North India. In conclusion, this study highlights the divergent evolution of SARS-CoV-2 strains and co-circulation of multiple clades in India. Monitoring of the emerging mutations would pave ways for vaccine formulation and designing of antiviral drugs.

resistant mutants leading to continuous need of developing new vaccines or drugs [5] . In the 68 context of urgent requirement of effective vaccine or antiviral drug against SARS-CoV2, it is 69 imperative to monitor the evolving mutations in the viral proteins. 70 Hence, this study was designed to analyse and compare the genetic mutations among SARS- 71 CoV-2 viruses across various geographical regions of India against the prototype "Wuhan 72 strain" [6] . Establishing an atlas of co-existing mutations across SARS-CoV-2 genome might 73 underscore their genetic evolution within the various epidemiological settings of India. Table 1 ). Several other 78 clade-specific reference gene sequences of SARS-CoV-2 were also downloaded from 79 GISAID for construction of the dendrogram. representative Indian strains (one from each of the 22 co-evolving mutant groups) ( Table 1) 179 along with strains denoting 10 different clades were selected for phylogenetic analyses. As and are found to be associated with the novel mutation T749I/NSP3.

The SARS-CoV-2 genome is accumulating mutations at a very high frequency. As suggested 288 by the "mutation-selection balance" and the "speed-fidelity trade-off" theories [20, 21] , this 289 might be because it has concentrated its endeavours to hasten its replication for increased 

The authors declare that no conflict of interest exists. 

A2a clade (55.60%) was found to be most prevalent in India, followed by A3 (37.38%) and B 426 (7%). 

A23403G (D614G)/S, C3037T (F106F)/NSP3, C241T/5'-UTR

G25563T (Q57H)/ORF3a, C28854T (S194L)/N, C22444T

A23403G (D614G)/S, C3037T (F106F)/NSP3, C241T/5'-UTR, C14408T (P323L)/RDRP, G25563T (Q57H)

A23403G (D614G)/S, C3037T (F106F)/NSP3, C241T/5'-UTR, C14408T (P323L)/RDRP, G25563T (Q57H)/ORF3a, G21759T (R78M)/S

A23403G (D614G)/S, C3037T (F106F)/NSP3, C241T/5'-UTR, C14408T (P323L)/RDRP, GGG28881AAC (RG203KR)/N

A23403G (D614G)/S, C3037T (F106F)/NSP3, C241T/5'-UTR, C14408T (P323L)/RDRP, GGG28881AAC (RG203KR)/N, C5700A (A994D)/NSP3

A23403G (D614G)/S, C3037T (F106F)/NSP3, C241T/5'-UTR, C14408T (P323L)/RDRP, C13730T (A97V)/RDRP

A23403G (D614G)/S, C3037T (F106F)/NSP3, C241T/5'-UTR, C14408T (P323L)/RDRP, G4866T (S716I)/NSP3, C14425A (L329I)/RDRP

G11083T (L37F)/NSP6, G1397A (V198I)/NSP2, G8653T (M33I)/NSP4, C884T (R27C)/NSP2

G11083T (L37F)/NSP6, C28311T (P13L)/N, C23929T (Y789Y)/S, C13730T (A97V)/RDRP, C6312A (T1198K)/NSP3

G11083T (L37F)/NSP6, C28311T (P13L)/N, C23929T (Y789Y)/S, C13730T (A97V)/RDRP, C6312A (T1198K)/NSP3, C6310A (S1197R)/NSP3

G11083T (L37F)/NSP6, C28311T (P13L)/N, C23929T (Y789Y)/S, C13730T (A97V)/RDRP, C6312A (T1198K)/NSP3, C6310A (S1197R)/NSP3, C1707T (S301F)/NSP2

G11083T (L37F)/NSP6, C28311T (P13L)/N, C23929T (Y789Y)/S, C13730T (A97V)/RDRP, C6312A (T1198K)/NSP3, C6310A (S1197R)/NSP3, G1820A (G339S)/NSP2

G11083T (L37F)/NSP6, C28311T (P13L)/N, C23929T (Y789Y)/S, C13730T (A97V)/RDRP, C6312A (T1198K)/NSP3, A6081G (D1121G)/NSP3

G11083T (L37F)/NSP6, C28311T (P13L)/N, C23929T (Y789Y)/S, C13730T (A97V)/RDRP, C6312A (T1198K)/NSP3, A21792T (K77M)/S

T28144C (L84S)/ORF8, C8782T (S76S)/NSP4, C4965T (T749I)/NSP3

EPI-ISL-452205, EPI-ISL-452207 -EPI-ISL-452217